# CDER’s Program for the Recognition of Voluntary Consensus Standards Related to Pharmaceutical Quality - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/cders-program-for-the-recognition-of-voluntary-consensus-standards-related-to-pharmaceutical-quality/8610d370-6b09-40a5-9d6b-24ac4df3f732

> FDA guidance document: CDER’s Program for the Recognition of Voluntary Consensus Standards Related to Pharmaceutical Quality. Issue date: July 26, 2023. Get complete insights and analysis.

---

## Details

- Title: CDER’s Program for the Recognition of Voluntary Consensus Standards Related to Pharmaceutical Quality
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2023-07-26
- Last Changed: 2023-07-26
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2018-D-4417">FDA-2018-D-4417</a>

## Related Documents

- [Smoking Cessation and Related Indications: Developing Nicotine Replacement Therapy Drug Products](https://www.globalkeysolutions.net/guidances/guidance-document/smoking-cessation-and-related-indications-developing-nicotine-replacement-therapy-drug-products/bdeb89b0-5451-4478-b053-64d1decc6de0)
- [Questions and Answers on Quality Related Controlled Correspondence Guidance for Industry:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/questions-and-answers-on-quality-related-controlled-correspondence-guidance-for-industry-guidance-for-industry/36e0e984-b134-47b6-bee8-6f25aa0282c1)
- [Nonclinical Evaluation of the Immunotoxic Potential of Pharmaceuticals](https://www.globalkeysolutions.net/guidances/guidance-document/nonclinical-evaluation-of-the-immunotoxic-potential-of-pharmaceuticals/160dff53-faf3-4095-b37e-414e108646cf)